| Julie Ann Fontenot, | |
|
100 Rivendell Dr, Benton, AR 72019-9188 | |
| (501) 316-1255 | |
| Not Available |
| Full Name | Julie Ann Fontenot |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 100 Rivendell Dr, Benton, Arkansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376722371 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Julie Ann Fontenot, 100 Rivendell Dr, Benton, AR 72019-9188 Ph: (501) 316-1255 | Julie Ann Fontenot, 100 Rivendell Dr, Benton, AR 72019-9188 Ph: (501) 316-1255 |
News Archive
New research has found that drug-resistant strains of tuberculosis are just as likely to be transmitted between people as drug-sensitive TB, which could make drug-resistant forms of the disease "highly prevalent in the next few decades," the Australian Associated Press/Sydney Morning Herald reports (Rose, 8/11).
Yale pharmacology professor Barbara Ehrlich and her team have uncovered a mechanism driving a rare, lethal disease called Wolfram Syndrome and also a potential treatment. Their findings appear in the July 6 edition of Proceedings of the National Academy of Sciences.
New research from the laboratory of Dr. Elizabeth Leadbetter at the Trudeau Institute may lead to a whole new class of vaccines. Dr. Leadbetter's lab has discovered new properties of a potential vaccine adjuvant that suggest it could be useful for enhancing protection against a number of different infections.
Uganda's Ministry of Health will provide the artemisinin-based combination therapy Coartem to private health clinics at subsidized prices to curb the spread of malaria in the country, Minister of State for Primary Health Care Emmanuel Otaala said Wednesday, New Vision reports.
Discovery Laboratories, Inc., a biotechnology company developing its novel synthetic surfactant and aerosol technologies for respiratory diseases, today provides an update on Surfaxin® and key pipeline and business initiatives and reports financial results for the first quarter ended March 31, 2010.
› Verified 9 days ago
Mrs. Ashleigh Rosinbaum, Counselor Medicare: Not Enrolled in Medicare Practice Location: 3214 Winchester, Benton, AR 72015 Phone: 501-326-6160 Fax: 501-326-6161 | |
Mrs. Lisa Dansby Williams, MS, LAC Counselor Medicare: Not Enrolled in Medicare Practice Location: 100 Rivendell Dr, Benton, AR 72015 Phone: 501-316-1255 Fax: 501-316-2221 | |
Michelle Leann Crews, Counselor Medicare: Not Enrolled in Medicare Practice Location: 3214 Winchester, Benton, AR 72015 Phone: 501-326-6160 | |
Elizabeth Sara Farmer, LCSW Counselor Medicare: Not Enrolled in Medicare Practice Location: 200 N Market St, Benton, AR 72015 Phone: 501-847-2229 | |
Belinda L Williams, Counselor Medicare: Not Enrolled in Medicare Practice Location: 100 Rivendell Dr, Benton, AR 72019 Phone: 501-316-1255 | |
Brian Kosters, CMP Counselor Medicare: Medicare Enrolled Practice Location: 6701 Highway 67, Benton, AR 72015 Phone: 501-315-3344 | |
Mrs. Amy Bradshaw, LCSW Counselor Medicare: Not Enrolled in Medicare Practice Location: 307 E Sevier St, Benton, AR 72015 Phone: 501-315-4224 Fax: 501-776-0411 |